Premier Biomedical, Inc. (BIEI)
0.0004
0.00 (0.00%)
USD |
OTCM |
Mar 06, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.52M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -33.33% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.98% |
Profile
| Premier Biomedical, Inc. engages in the development of graphene enhanced formulations for commercial and military applications. It also focuses on Electric Vehicle battery technology and ballistic gear. The company was founded by Mitchell S. Felder on May 10, 2010 and is headquartered in El Centro, CA. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | California |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Premier Biomedical, Inc. engages in the development of graphene enhanced formulations for commercial and military applications. It also focuses on Electric Vehicle battery technology and ballistic gear. The company was founded by Mitchell S. Felder on May 10, 2010 and is headquartered in El Centro, CA. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | California |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |